key: cord-0833353-3vssz3ah authors: AL-Kaf, Fahmi A.; AL Garni, Turki A.; AL-Harbi, Nahes; Sandokji, Hassan; Samargandy, Sondos title: Cardiac Tamponade, Sever Hypothyroidism and Acute Respiratory Distress Syndrome (ARDS) with COVID-19 Infection date: 2021-04-19 journal: J Saudi Heart Assoc DOI: 10.37616/2212-5043.1235 sha: ff14f22757617771c329230e732340da7261f44b doc_id: 833353 cord_uid: 3vssz3ah A 21-years-old with Down syndrome presented with respiratory distress. Initial investigations revealed a cardiac tamponade. On further evaluation, he had positive coronavirus disease-2019 (COVID-19), severe chest infection and severe hypothyroidism. He responded well to urgent pericardiocentesis, levothyroxine, hydrocortisone and tocilizumab. A 21-year-old with Down syndrome was brought into the emergency department (ED) by his mother with a complaint of shortness of breath for two days. His presentation preceded by three days of flu-like symptoms, including runny nose, cough and reduced oral intake and vomiting. On examination, he was in distress, respiratory rate of 28 breaths/min, oxygen saturation 95% on 15 L non-rebreathing mask, blood pressure (BP) of 85/60 mm Hg, heart rate of 68 beats/min, temperature of 36.4C, raised JVP, distant heart sounds and diminished breath sounds over the lower left lung field. The patient had a past medical history of congenital tracheobronchomalacia, which was treated successfully with surgical intervention during neonatal age. He had no past medical history of weight gain, weakness, cold intolerance, hoarseness, or changes in his mental status or bowel habits. The differential diagnosis includes COVID-19 pneumonia, viral pericarditis and cardiac tamponade. In the absence of expected compensatory tachycardia during cardiac tamponade, we include hypothyroidism as one of the differential diagnosis. An urgent echo-guided pericardiocentesis from an apical approach was performed, draining 950 cc of an exudative straw color fluid. The blood pressure was recovered immediately following pericardiocentesis (BP ΒΌ 102/71). However, the patient was in respiratory distress, not responded to initial non-invasive positive pressure ventilation (NIPPV), and underwent elective intubation. The pericardial fluid analysis revealed exudative results of total protein (TP) of 85 g/L (pericardial fluid TP/serum TP > 0.5), total fluid WBC of 253 cells/microL with a predominance of polymorphonuclear leukocytes 62.3%, mononuclear cells of 37.6%, and no fluid cultures growth. Pericardial fluid cytology showed atypical cell appearance, and no malignant cells could be seen. On the night of admission day, severe hypothyroidism managed with intravenous levothyroxine and hydrocortisone for few days then changed to oral form through a nasogastric tube. In the hope of growing reported evidence of anticoagulation to reduce mortality in patients with severe COVID-19 with coagulopathy, therapeutic heparin infusion started. 1 However, over the initial five days of admission, the patient was critically ill and clinically deteriorated. He developed acute respiratory distress syndrome (ARDS) with increased of bilateral lung Coronavirus disease-2019 (COVID-19) represents a potentially fatal disease that causes massive destruction in the health care system. Herein, we report a case of Down syndrome who developed COVID-19 infection, presented with cardiac tamponade, chest infection and severe hypothyroidism. Among all COVID-19 previous reported cases, the present case is the first suchlike clinical presentation. COVID-19 clinical manifestations are not limited to the respiratory system, and other organs can be affected. 2 It is hypothesized that COVID-19 virus can cause systemic dysfunction by direct cytotoxic effects or immune-mediated excessive cytokines release termed cytokines storm. 3 Although viral pericarditis is the most common cause of pericardial effusion, 4 there are few reported cases of COVID-19 who developed cardiac tamponade. 5, 6, 7 Tocilizumab is an IL-6 receptor (IL-6R) blocker that had a promised initial efficacy data in cytokines storm management. 3 In the present case general condition, respiratory illness and pancytopenia respond well to tocilizumab treatment. On the other hand, hypothyroidism is a common cause of pericardial effusion. 8 However, owing to a slow accumulation of pericardial fluid, hypothyroidism rarely causes cardiac tamponade. 8 Provocative factors (for example, viral infection) usually precede most of hypothyroidism related cardiac tamponade. 8 Thyroid dysfunctions, particularly overt and subclinical hypothyroidism, are common in Down syndrome, with a prevalence varies between 4% and 18%, and autoimmune antibodies are one of the hypothesized causes. 9, 10 The early recognition of hypothyroidism in Down syndrome can be difficult and annual screening of thyroid function tests are recommended. 10 In the present case, positive anti-thyroid antibodies raise a possibility of previous subclinical or overt hypothyroidism, which rapidly deteriorated to severe form and cardiac tamponade provoked by COVID-19 infection. Medical treatment of hypothyroidism and large pericardial effusion with levothyroxine demonstrate a good effusion resolution effect. 8 However, pericardiocentesis indicated for diagnostic sample or therapeutic medical emergency in hypothyroidism patients with cardiac tamponade. 8 The first negative NPS of COVID-19 recorded on the 25th day of admission. After a total of 31 days of mechanical ventilation support, the patient successfully weaned off and planned for tracheostomy closure. CXR and ECG changes were almost resolved ( Figure 6,7) . We report a rare critical presentation of COVID-19 in Down syndrome patient with cardiac tamponade, ARDS and severe hypothyroidism. The patient responds well to pericardiocentesis, levothyroxine, hydrocortisone and tocilizumab. This case highlights the early recognition of a rare extrapulmonary manifestation of COVID-19 can save patients life with proper management. The author(s) received no financial support for the research, authorship, and/or publication of this article. Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy Extra-respiratory manifestations of COVID-19 Cytokine release syndrome in severe COVID-19: interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortality Evaluation and treatment of pericarditis: a systematic review SARS-CoV-2 detection in the pericardial fluid of a patient with cardiac tamponade Electrocardiogram: sinus rhythm with resolved low voltage QRS Life-threatening cardiac tamponade complicating myo-pericarditis in COVID-19 Hypothyroid cardiac tamponade: clinical features, electrocardiography, pericardial fluid and management Thyroid dysfunction in children with Down syndrome: a literature review Committee on Genetics. Health supervision for children with Down syndrome All authors have none to declare.